Mortality in type 1 diabetes in the DCCT/EDIC versus the general population

Diabetes Care

Volumn 39, Issue 8, 2016, Pages 1378-1383

  Lachin, John M ^a   Bebu, Ionut ^a   Nathan, David M ^b   Zinman, Bernard ^c   Brillon, David ^d   Backlund, Jye Yu C ^a   Cleary, Patricia ^a   Orchard, Trevor J ^e  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ALBUMINURIA; ALLOPATHY; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE SYSTEM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RATE; PATIENT CARE; POISSON DISTRIBUTION; POPULATION RESEARCH; PRIMARY PREVENTION; REGRESSION ANALYSIS; RESTING METABOLIC RATE; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGY; FOLLOW UP; GLUCOSE BLOOD LEVEL; METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84980360928     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-2399     Document Type: Article

References (31)

1. Borch-Johnsen K, Kreiner S, Deckert T. Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 1986; 29:767-772
2. Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ 2011; 343:d5364
3. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patientsin Norway. Diabetologia 2006; 49: 298-305
4. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006; 49: 660-666
5. Shankar A, Klein R, Klein BEK, Moss SE. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol 2007; 166:393-402
6. Podar T, Solntsev A, Reunanen A, et al. Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts. Diabetes Care 2000; 23:290-294
7. Asao K, Sarti C, Forsen T, et al.; Diabetes Epidemiology Research International Mortality Study Group. Long-term mortalityinnationwidecohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 2003; 26:2037-2042
8. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55:1463-1469
9. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 2010; 33:2573-2579
10. McNally PG, Raymond NT, Burden ML, et al. Trends in mortality of childhood-onset insulin dependent diabetes mellitus in Leicestershire: 1940-1991. Diabet Med 1995; 12:961-966
11. Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes 2012; 61:2987-2992
12. Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1diabetes: Scottish registry linkage study. PLoS Med 2012; 9: e1001321
13. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014; 371:1972-1982
14. Orchard TJ, Nathan DM, Zinman B, et al.; Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015; 313:45-53
15. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986
16. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22:99-111
17. Nathan DM, Bayless M, Cleary P, et al.; DCCT/EDIC Research Group. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes 2013; 62:3976-3986
18. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep 2016; 64:1-119
19. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. London, Blackwell Scientific Publications, 1994
20. Lachin JM Biostatistical Methods: The Assessment of Relative Risks. 2nd ed. Hoboken, NJ, John Wiley and Sons, 2011
21. Atkinson EJ, Crowson CS, Pedersen RA, Therneau TM. Poisson models for person-years and expected rates. Technical report #81 [Internet], 2008. Available from http://www.mayo.edu/research/documents/biostat-81pdf/doc10026981. Accessed 31 August 2015
22. Hastie T, Tibshirani R. Generalized Additive Models. London, Chapman and Hall, 1990
23. de Boer IH, Sun W, Gao X, et al.; DCCT/EDIC research group. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol 2014; 2: 793-800
24. Groop PH, Thomas MC, Moran JL, et al.; FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all cause mortality in type 1 diabetes. Diabetes 2009; 58:1651-1658
25. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010; 53:2312-2319
26. Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME; DCCT/EDIC Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year followup of the Diabetes Control and Complications/ Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care 2013; 36: 3131-3138
27. Cirino PT, Chin CE, Sevcik RA, Wolf M, Lovett M, Morris RD. Measuring socioeconomic status: reliability and preliminary validity for different approaches. Assessment 2002; 9:145-155
28. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, I: all cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16:459-465
29. Sex differences in the mortality associated with insulin-dependent diabetes mellitus in four countries. The Diabetes Epidemiology Research International (DERI) Study. Am J Epidemiol 1991; 133:577-584
30. Brown LJ, Scott RS, Moir CL. All-cause mortality in the Canterbury (New Zealand) insulin treated Diabetic Registry population. Diabetes Care 2001; 24:56-63
31. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group; Nathan DM, Zinman B, Cleary PA, et al. Modern day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study and Pittsburgh Epidemiology of Diabetes Complications experience (1983-2005). Arch Intern Med 2009; 169:1307-1316